Cubol, Emelda D.

HRN: 28-68-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2026
03/26/2026
IV
4.5
Q6H
UROSEPSIS, SEPSIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: Compliant To Guidelines